Newswise — Researchers are studying messenger RNA’s potential to treat and prevent an array of serious conditions—including cancer.
In a briefing for journalists by Johns Hopkins University and Medicine, mRNA researchers will offer broad perspective on the history and development of this technology and discuss its future promise as the foundation for treatments for conditions including autoimmune diseases, infectious diseases, and various cancers.
WHEN: 11 a.m., Thursday, April 10.
REGISTRATION: This is a briefing for journalists only. For the link to register, contact Jill Rosen: [email protected].
Q&A: The session will be on the record, and there will be an opportunity to ask questions. Questions can be submitted in advance, or in chat during the briefing.
Speakers will include:
, the Bloomberg Distinguished Professor of RNA Biology and Therapeutics who has studied mRNA for more than 30 years.
, an oncologist focused on immune-based therapies for pancreatic and breast cancers, and deputy director of the Sidney Kimmel Comprehensive Cancer Center.
, a biomedical engineer who develops new biotechnology to improve the delivery system of mRNA.
RSS